Low immunoreactivity of AKR1C3 was detected in normal prostate epithelium, benign prostatic hyperplasia (BPH) and prostatic intraepithelial neoplasia (PIN). This evidence concerns the gene AKR1C3 and benign prostatic hyperplasia.